Autologous non‐myeloablative non‐selective HSCT vs cyclophosphamideOverall mortality · people with systemic sclerosis1 finding from 1 reviewStem cell transplantation for systemic sclerosis 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 19 participantsLow